References
- IAVI, Ballou WR, Baylor N, Cueni T, Dzau V, Fukuda K, Garcia PJ, Gupta A, Kadilli E, Kerr L, et al. Influenza imperative: an urgent need to leverage lessons from COVID-19 to prepare for a global response to seasonal and pandemic influenza. NAM Perspect. 2022;9. 10.31478/202209b.
- Janssen C, Mosnier A, Gavazzi G, Combadière B, Crépey P, Gaillat J, Launay O, Botelho-Nevers E. Coadministration of seasonal influenza and COVID-19 vaccines: a systematic review of clinical studies. Hum Vaccines Immunother. 2022;18(6):2131166. doi: 10.1080/21645515.2022.2131166.
- Bonanni P, Steffen R, Schelling J, Balaisyte-Jazone L, Posiuniene I, Zatoński M, Van Damme P. Vaccine co-administration in adults: an effective way to improve vaccination coverage. Hum Vaccines Immunother. 2023;19(1):2195786. doi: 10.1080/21645515.2023.2195786.
- Venuto R, Giunta I, Cortese R, Denaro F, Pantò G, Privitera A, D’Amato S, Genovese C, La Fauci V, Fedele F, et al. The importance of COVID-19/influenza vaccines co-administration: an essential public health tool. Infect Dis Rep. 2022;14(6):987–7. doi:10.3390/idr14060098.
- WHO. Coadministration of seasonal inactivated influenza and COVID-19 vaccines; Published online 2021 Oct 21 [accessed 2023 Aug 1]. https://apps.who.int/iris/bitstream/handle/10665/346897/WHO-2019-nCoV-SAGE-Vaccines-coadministration-Influenza-2021.1-eng.pdf?sequence=1&isAllowed=y.
- Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett SR, Garstang J, Gbadamoshi L, Hallis B, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdox1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFlucov): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021;398(10318):2277–87. doi:10.1016/S0140-6736(21)02329-1.
- Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(2):167–79. doi:10.1016/S2213-2600(21)00409-4.
- Hause AM, Zhang B, Yue X, Marquez P, Myers TR, Parker C, Gee J, Su J, Shimabukuro TT, Shay DK, et al. Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Netw Open. 2022;5(7):e2222241. doi:10.1001/jamanetworkopen.2022.22241.
- Domnich A, Orsi A, Trombetta CS, Guarona G, Panatto D, Icardi G. COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy. Pharmaceuticals. 2022;15(3):322. doi:10.3390/ph15030322.
- CDC. Use of COVID-19 vaccines in the United States interim clinical considerations; 2023 Aug 1 [accessed 2021 Dec 13]. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#Coadministration.
- Grohskopf LA, Alyanak E, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2021–22 influenza season. MMWR Recomm Rep. 2021;70(5):1–28. doi:10.15585/mmwr.rr7005a1.
- Ministero della Salute. FAQ - Influenza e vaccinazione antinfluenzale [ accessed 2023 Aug 1]. https://www.salute.gov.it/portale/p5_1_1.jsp?lingua=italiano&faqArea=influenza&id=103.
- Domnich A, Grassi R, Fallani E, Ciccone R, Bruzzone B, Panatto D, Ferrari A, Salvatore M, Cambiaggi M, Vasco A, et al. Acceptance of COVID-19 and influenza vaccine co-administration: insights from a representative Italian survey. J Pers Med. 2022;12(2):139. doi:10.3390/jpm12020139.
- Lecce M, Biganzoli G, Agnello L, Belisario I, Cicconi G, D’Amico M, De Giorgi F, Ferilli A, Ferraguzzi G, Guzzardi F, et al. COVID-19 and influenza vaccination campaign in a research and University hospital in Milan, Italy. Int J Environ Res Public Health. 2022;19(11):6500. doi:10.3390/ijerph19116500.
- Ministero della Salute. Piano nazionale prevenzione vaccinale [ accessed 2023 Jul 15]. https://www.salute.gov.it/portale/vaccinazioni/dettaglioContenutiVaccinazioni.jsp?lingua=italiano&id=4828&area=vaccinazioni&menu=vuoto.
- Riassunto delle caratteristiche del prodotto comirnaty original/Omicron BA.4-5 [ accessed 2023 Nov 2]. https://www.aifa.gov.it/documents/20142/1279946/050306_COMIRNATY_ORIGINAL-OMICRON_BA.4-5_06.10.2022.pdf.
- Riassunto caratteristiche del prodotto VaxigripTetra [ accessed 2023 Nov 2]. https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_004285_044898_RCP.pdf&sys=m0b1l3.
- Riassunto caratteristiche del prodotto FluadTetra [ accessed 2023 Nov 2]. https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_004980_048797_RCP.pdf&sys=m0b1l3.
- Riassunto delle caratteristiche del prodotto FlucelvaxTetra [ accessed 2023 Nov 2]. https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_004980_047475_RCP.pdf&sys=m0b1l3.
- Haviari S, Bénet T, Saadatian-Elahi M, André P, Loulergue P, Vanhems P. Vaccination of healthcare workers: a review. Hum Vaccines Immunother. 2015;11(11):2522–37. doi: 10.1080/21645515.2015.1082014.
- Cohen B, Hyman S, Rosenberg L, Larson E. Frequency of patient contact with health care personnel and visitors: implications for infection prevention. Jt Comm J Qual Patient Saf. 2012;38(12):560–5. doi: 10.1016/S1553-7250(12)38073-2.
- Sood G, Perl TM. Outbreaks in health care settings. Infect Dis Clin North Am. 2016;30(3):661–87. doi: 10.1016/j.idc.2016.04.003.
- Music T. Protecting patients, protecting healthcare workers: a review of the role of influenza vaccination. Int Nurs Rev. 2012;59(2):161–7. doi: 10.1111/j.1466-7657.2011.00961.x.
- Gazzetta Ufficiale della Repubblica Italiana. DECRETO-LEGGE 31 ottobre 2022, n. 162 [ accessed 2023 Aug 1]. https://www.gazzettaufficiale.it/eli/id/2022/10/31/22G00176/sg.
- Gazzetta Ufficiale della Repubblica Italiana. DECRETO-LEGGE 24 marzo 2022, n. 24 [ accessed 2023 Aug 1]. https://www.gazzettaufficiale.it/eli/id/2022/03/24/22G00034/sg.
- Pascucci D, Grossi A, Lontano A, Marziali E, Nurchis M, Grassi V, Raponi M, Vetrugno G, Capelli G, Calabrò G, et al. Risk of infection and duration of protection after the booster dose of the anti-SARS-CoV-2 vaccine BNT162b2 among healthcare workers in a large teaching hospital in Italy: results of an observational study. Vaccines. 2022;11(1):25. doi:10.3390/vaccines11010025.
- Pascucci D, Nurchis MC, Sapienza M, Castrini F, Beccia F, D’Ambrosio F, Grossi A, Castagna C, Pezzullo AM, Zega M, et al. Evaluation of the effectiveness and safety of the BNT162b2 COVID-19 vaccine in the vaccination campaign among the health workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Int J Environ Res Public Health. 2021;18(21):11098. doi:10.3390/ijerph182111098.
- Pascucci D, Nurchis MC, Lontano A, Marziali E, Vetrugno G, Cambieri A, Moscato U, Di Pilla A, Damiani G, Laurenti P, et al. Flu and COVID-19 vaccination: what happens to the Flu shot when the campaigns overlap? Experience from a large Italian research hospital. Vaccines. 2022;10(6):976. doi:10.3390/vaccines10060976.
- GOV.UK. Seasonal influenza vaccine uptake in frontline healthcare workers in England: winter season 2022 to 2023 [ accessed 2023 Aug 1]. https://www.gov.uk/government/statistics/seasonal-influenza-vaccine-uptake-in-frontline-healthcare-workers-in-england-winter-season-2022-to-2023/seasonal-influenza-vaccine-uptake-in-frontline-healthcare-workers-in-england-winter-season-2022-to-2023.
- Di Pumpo M, Vetrugno G, Pascucci D, Carini E, Beccia V, Sguera A, Zega M, Pani M, Cambieri A, Nurchis MC, et al. Is COVID-19 a real incentive for Flu vaccination? Let the numbers speak for themselves. Vaccines. 2021;9(3):276. doi:10.3390/vaccines9030276.
- Moro PL, Zhang B, Ennulat C, Harris M, McVey R, Woody G, Marquez P, McNeil MM, Su JR. Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022. Vaccine. 2023;41(11):1859–63. doi: 10.1016/j.vaccine.2022.12.069.
- Stefanizzi P, Martinelli A, Bianchi FP, Migliore G, Tafuri S. Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs. Hum Vaccines Immunother. 2022;18(1):1–2. doi: 10.1080/21645515.2021.2011652.
- Nutman A, Yoeli N. Influenza vaccination motivators among healthcare personnel in a large acute care hospital in Israel. Isr J Health Policy Res. 2016;5(1):52. doi:10.1186/s13584-016-0112-5.
- Christini AB, Shutt KA, Byers KE. Influenza vaccination rates and motivators among healthcare worker groups. Infect Control Hosp Epidemiol. 2007;28(2):171–7. doi: 10.1086/511796.
- Wicker S, Rabenau HF, Doerr HW, Allwinn R. Influenza vaccination compliance among health care workers in a German University Hospital. Infection. 2009;37(3):197–202. doi:10.1007/s15010-008-8200-2.
- Luo C, Yang Y, Liu Y, Zheng D, Shao L, Jin J, He Q. Intention to COVID-19 vaccination and associated factors among health care workers: a systematic review and meta-analysis of cross-sectional studies. Am J Infect Control. 2021;49(10):1295–304. doi: 10.1016/j.ajic.2021.06.020.
- Nagata JM, Hernández-Ramos I, Kurup AS, Albrecht D, Vivas-Torrealba C, Franco-Paredes C. Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data. BMC Public Health. 2013;13(1):388. doi:10.1186/1471-2458-13-388.
- Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: a systematic review and meta-analysis of acceptability and its predictors. Prev Med. 2021;150:106694. doi:10.1016/j.ypmed.2021.106694.
- Nehal KR, Steendam LM, Campos Ponce M, Van Der Hoeven M, Smit GSA. Worldwide vaccination willingness for COVID-19: a systematic review and meta-analysis. Vaccines. 2021;9(10):1071. doi:10.3390/vaccines9101071.
- Pavlovic D, Sahoo P, Larson HJ, Karafillakis E. Factors influencing healthcare professionals’ confidence in vaccination in Europe: a literature review. Hum Vaccines Immunother. 2022;18(1):2041360. doi: 10.1080/21645515.2022.2041360.
- Czajka H, Czajka S, Biłas P, Pałka P, Jędrusik S, Czapkiewicz A. Who or what influences the individuals’ decision-making process regarding vaccinations? Int J Environ Res Public Health. 2020;17(12):4461. doi: 10.3390/ijerph17124461.
- Imai C, Toizumi M, Hall L, Lambert S, Halton K, Merollini K, Ortiz JR. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers. Ortiz JR, ed. PLoS ONE. 2018;13(6):e0198685. doi: 10.1371/journal.pone.0198685.
- Cella MT, Corona G, Tuccillo E, Franco G. Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting. Med Lav. 2005;96:483–9.
- Meijboom MJ, Riphagen‐Dalhuisen J, Hak E. The potential economic value of influenza vaccination for healthcare workers in the Netherlands. Influenza Other Respir Viruses. 2018;12(4):457–64. doi: 10.1111/irv.12558.
- Nurchis MC, Lontano A, Pascucci D, Sapienza M, Marziali E, Castrini F, Messina R, Regazzi L, Causio FA, Di Pilla A, et al. COVID-19 vaccination campaign among the health workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS: a cost–benefit analysis. Int J Environ Res Public Health. 2022;19(13):7848. doi:10.3390/ijerph19137848.